Kyndryl Holdings ($KD) Misstatements About Cash Reporting and Internal Controls Case
$KD investors filed a claim against Kyndryl Holdings for allegedly misleading investors about its financial reporting, including cash management practices and related disclosures, and the effectiveness of its internal control over financial reporting.
After Kyndryl disclosed an Audit Committee review tied to voluntary SEC Enforcement document requests, expected material weaknesses in internal controls, along with the CFO and General Counsel’s immediate departures and a delayed 10-Q filing—$KD fell 55% on February 9, 2026.
$KD investors can join this case to be notified about potential recovery.
Case Details:
Between Aug. 7, 2024 and Feb. 9, 2026, Kyndryl told investors its reporting and internal controls were effective (including as of Mar. 31, 2025) and that any control issues were limited and being addressed. Investors allege the company’s financial statements were materially misstated, internal controls were inadequate, and the extent of the issues was understated—creating risk of a delayed Dec. 31, 2025 quarter 10-Q filing.
On Feb. 9, 2026, Kyndryl filed a late-filing notice for its 10-Q and disclosed voluntary document requests from the SEC Enforcement Division. It said the Audit Committee is reviewing cash management and related disclosures (including adjusted free cash flow drivers), expects material weaknesses in internal controls across multiple periods, and that its FY2025 10-K internal-control assessment and auditor opinion should no longer be relied upon. Shares fell 55% ($12.90) to $10.59.
That same day, Kyndryl also announced the immediate departures of its CFO and General Counsel.
Based on these events, $KD investors filed a claim against Kyndryl Holdings, Inc., alleging the company:
It issued materially misstated financial statements during the Class Period
It lacked adequate internal controls and understated the extent of internal control issues
It could not timely file its quarterly report (Form 10-Q) for the quarter ended December 31, 2025, and misled investors about its business and prospects as a result
Investors argue Kyndryl misled the market about the reliability of its financial reporting and internal controls, causing losses when the company disclosed the SEC-related review, expected material weaknesses, reliance withdrawal, leadership departures, and delayed filing.